TY - GEN AU - Serra,Raffaele AU - Serra,Raffaele TI - Matrix Metalloproteinases in Health and Disease SN - books978-3-03943-053-6 PY - 2020/// CY - Basel, Switzerland PB - MDPI - Multidisciplinary Digital Publishing Institute KW - Humanities KW - bicssc KW - Social interaction KW - hypersensitivity pneumonitis KW - metalloproteinases KW - genetic association KW - autoantibodies KW - MMP1 KW - MMP2 KW - SNPs KW - MMPs KW - TIMPs KW - CKD KW - peripheral vascular disease KW - biomarkers KW - proteinuria KW - eGFR KW - PAD KW - NGAL KW - statins KW - arterial aneurysms KW - patients KW - collagenases KW - Crohn's disease KW - dental caries KW - mouth KW - periodontitis KW - matrix metalloproteinase-9 KW - dialysis KW - on-line hemodiafiltration KW - high-flux dialysis KW - renal replacement therapy KW - kidney transplantation KW - Mac-1 KW - CD147 KW - leukocytes KW - platelets KW - adhesion KW - integrin αMβ2 KW - matrix metalloproteinases KW - TIMP KW - synthetic inhibitors KW - RECK KW - matrix metalloproteinase KW - MAPKs KW - ischemia/reperfusion KW - eNOS KW - iNOS KW - inflammatory bowel disease KW - inflammation KW - NO KW - MMP-9 KW - cGMP KW - Caco-2 KW - matrix metalloproteinase-7 KW - fibrosis KW - acute kidney injury KW - chronic kidney disease KW - apoptosis KW - health KW - disease N1 - Open Access N2 - Matrix metalloproteinases (MMPs) are members of an enzyme family and are critical for maintaining tissue allostasis. MMPs can catalyze normal turnover of the extracellular matrix (ECM) together with other metalloproteinases such as ADAM (a disintegrin and metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) families. MMP activity is also regulated by a group of endogenous proteins called tissue inhibitor of metalloproteinases (TIMPs). All these proteins have a pivotal role involving ECM remodelling in normal physiological processes such as wound healing, embryogenesis, angiogenesis, bone remodelling, immunity, and the female reproductive cycle. An imbalance in the expression or activity of MMPs can also have important consequences in diseases such as cancer, cardiovascular disease, peripheral vascular disease, chronic leg ulcers, and multiple sclerosis. In recent years, MMPs have been found to play an important role in the field of precision medicine, as they may serve as biomarkers that may predict an individual's disease predisposition, state, or progression. MMPs are also thought to be a sensible target for molecular therapy. The aim of this Special Issue is to explore the most recent findings in this field that may have an impact in healthcare systems UR - https://mdpi.com/books/pdfview/book/2831 UR - https://directory.doabooks.org/handle/20.500.12854/69062 ER -